Phio Pharmaceuticals Corp (NASDAQ:PHIO)

2.39
Delayed Data
As of Dec 04
 +0.04 / +1.70%
Today’s Change
1.60
Today|||52-Week Range
13.61
-74.59%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$13.0M

Company Description

Phio Pharmaceuticals Corp. is a biotechnology company, which engages in the development of immuno-oncology therapeutics that addresses unmet medical needs. Its clinical product candidate includes RXI-109, an RNAi compound developed for the reduction of dermal scarring in planned surgeries. The company was founded on September 8, 2011 and is headquartered in Marlborough, MA.

Contact Information

Phio Pharmaceuticals Corp.
257 Simarano Drive
Marlborough Massachusetts 01752
P:(508) 767-3861
Investor Relations:

Employees

Shareholders

Other institutional1.03%
Mutual fund holders0.12%
Individual stakeholders0.03%

Top Executives

Gerrit DispersynPresident & Chief Executive Officer
James CardiaVice President-Business Operations
Caitlin KontulisSecretary, VP-Finance & Administration
Simon FrickerVice President-Research